NCT06540456View on ClinicalTrials.gov

Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy

Enrolling by invitationOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

July 3, 2027

Study Completion Date

July 3, 2028

Conditions
Lower Back PainLumbosacral Radiculopathy
Interventions
DRUG

Qutenza® 8% Capsaicin Topical System

Treatment of patients with neuropathic LBP and painful lumbosacral radiculopathy using the Qutenza 8% capsaicin topical system.

Trial Locations (1)

29483

MUSC Health Nexton Medical Park, Summerville

Sponsors

Collaborators (1)

Averitas Pharma, Inc.
All Listed Sponsors
collaborator

Averitas Pharma, Inc.

INDUSTRY

lead

Medical University of South Carolina

OTHER